Search
Search
Faruk Orge, MD; Darius Moshfeghi, MD
Show Description +
How do ophthalmologists decide how best to treat retinopathy of prematurity? And what are best practices for treating patients? Faruk Orge, MD, and Darius Moshfeghi, MD, discuss the current state of treatment, look forward to the future, and explore how changes to telemedicine could impact patient care.
Posted: 12/12/2024
Faruk Orge, MD; Darius Moshfeghi, MD
How do ophthalmologists decide how best to treat retinopathy of prematurity? And what are best practices for treating patients? Faruk Orge, MD, and Darius Moshfeghi, MD, discuss the current state of treatment, look forward to the future, and explore how changes to telemedicine could impact patient care.
Posted: 12/12/2024
About Regeneron
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, Regeneron's unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in Regeneron's laboratories.
Visit us online: regeneron.com
Follow Regeneron
Copyright © 2024 Regeneron Pharmaceuticals Inc. All rights reserved.
